ASTERDM - Swing Trade Analysis with AI Signals

Last Updated Time : 19 Sept 25, 2:15 pm

Swing Trade Rating: 3.7

📊 Technical & Momentum Analysis

Price vs DMA: Trading above both 50-DMA (₹607) and 200-DMA (₹539), indicating a bullish structure with trend support.

RSI (47.9): Neutral zone — no momentum signal, but not oversold either.

MACD (4.85): Positive crossover — confirms mild upward momentum.

Volume: Significantly above 1-week average — strong participation, potential accumulation.

📈 Fundamental Snapshot

Metric Value Interpretation

P/E 98.6 Extremely overvalued vs industry PE (57.3) — valuation risk

PEG Ratio 0.33 Attractive — growth is undervalued, supports tactical swing

ROCE / ROE 139% / 200% Exceptionally high — likely inflated due to accounting or one-off factors

Debt-to-Equity 0.53 Moderate leverage — acceptable for healthcare sector

PAT Growth (QoQ) +1.7% Flat earnings — sentiment neutral

FII/DII Change -2.02% / +0.70% Mixed institutional sentiment — mild caution

🧠 Swing Trade Logic

Bias: Momentum setup with PEG support and strong volume, but valuation and ROCE/ROE figures may be distorted.

Catalyst: MACD strength + volume surge + PEG alignment.

Risk: Elevated P/E, questionable ROCE/ROE, and flat earnings — entry should be tightly managed.

🎯 Optimal Entry Price

Buy Zone: ₹600–₹610

(Pullback toward 50-DMA with stop-loss below ₹585)

🚪 Exit Strategy

If Already Holding

Target Exit: ₹640–₹655 (Resistance zone near recent swing highs)

Stop-Loss: ₹585 (Below 50-DMA and MACD base)

Selva, this setup fits a short-term tactical basket with momentum confirmation and PEG safety, but it’s not ideal for margin-of-safety logic. If you're refining your healthcare rotation, I can scan for peers with cleaner ROCE and breakout overlays. Let’s build that next layer when you're ready.

Edit in a page